Protokinetix: Funding, Investors & Team (Oct 2026)
Research and development company ProtoKinetix (PKTX) is setting the standard for cell survival technologies. An great possibility exists for its unique anti-aging glycopeptide (AAGP) to significantly influence the fields of ophthalmology, dermatology, transplant support, and biomanufacturing in the future. This anti-aging glycopeptide, which is based on a molecule from nature that a top-notch research team has harnessed to enable more cells survive longer, has the potential to completely transform healthcare. With AAGP, medical treatments will be more efficient, more accessible, and more inexpensive. The development of treatments for ailments like Type 1 diabetes, macular degeneration, heart disease, and stroke will advance More people will receive the therapies they need, and more lives will be improved.
Protokinetix has raised $340k across 2 funding rounds on record, the most recent a Seed of $110k announced in Jan 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Protokinetix Company Profile and Key Stats
Latest funding round on record: Jan 2023.
Protokinetix Funding Rounds
Protokinetix raised $230k in a Seed announced in Oct 2022.
3 months later, a Seed of $110k was announced in Jan 2023.
Protokinetix Founders and Leadership Team
Contact details for the Protokinetix team: 1 of 1 has an email address on file.
Start 14-day free trial →Protokinetix Funding Compared to Other Biotechnology Startups
Protokinetix's latest round of $110k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Protokinetix in Biotechnology and Marietta
Companies Similar to Protokinetix
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Protokinetix Funding FAQs
What does Protokinetix do?
Research and development company ProtoKinetix (PKTX) is setting the standard for cell survival technologies. An great possibility exists for its unique anti-aging glycopeptide (AAGP) to significantly influence the fields of ophthalmology, dermatology, transplant support, and biomanufacturing in the future. This anti-aging glycopeptide, which is based on a molecule from nature that a top-notch research team has harnessed to enable more cells survive longer, has the potential to completely transform healthcare. With AAGP, medical treatments will be more efficient, more accessible, and more inexpensive. The development of treatments for ailments like Type 1 diabetes, macular degeneration, heart disease, and stroke will advance More people will receive the therapies they need, and more lives will be improved.
How much funding has Protokinetix raised?
Protokinetix has raised $340k across 2 rounds on record. The most recent is a Seed of $110k announced in Jan 2023.
When did Protokinetix last raise funding?
Protokinetix's most recent funding round on record is a Seed of $110k, announced in Jan 2023.
Who is the CEO of Protokinetix?
Clarence Smith is listed as CEO at Protokinetix.
Where is Protokinetix headquartered?
Protokinetix is based in Marietta, Ohio, United States.
How many employees does Protokinetix have?
Protokinetix is in the 1-10 employee band.
How does Protokinetix's funding compare to other Biotechnology startups?
Protokinetix's latest round of $110k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Protokinetix Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Protokinetix is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.